NLM Digital Collections

Search

Start Over Subjects Opiate Substitution Treatment ✖Remove constraint Subjects: Opiate Substitution Treatment Subjects Opioid-Related Disorders -- drug therapy ✖Remove constraint Subjects: Opioid-Related Disorders -- drug therapy

11. Opioid use decreased in Medicare Part D, while medication-assisted treatment increased

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Drug Overdose -- drug therapy
Drug Utilization -- trends
Forecasting
Inappropriate Prescribing
Naloxone -- therapeutic use
State Government
Humans
United States

12. MAT in the emergency department: FAQ

Author(s):
Newman, Sandra, author
Publication:
[Oakland, California] : California Health Care Foundation, March 2019
Subject(s):
Emergency Medical Services
Emergency Service, Hospital
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Substance-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Inservice Training
Methadone -- therapeutic use
State Government
Telemedicine
Humans
California
United States

13. MAT for hospitalized patients

Author(s):
Newman, Sandra, author
Publication:
[Oakland, California] : California Health Care Foundation, June 2019
Subject(s):
Hospitalization
Inpatients
Insurance, Health, Reimbursement
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Drug Costs
Hospital Costs
Methadone -- therapeutic use
Reimbursement Mechanisms
State Government
Humans
California
United States

16. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States

17. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

18. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

20. How community health centers are addressing the opioid epidemic: case study

Author(s):
Hayes, Robert M., author
Squitieri, Joseph, author
Publication:
New York, NY : Milbank Memorial Fund, April 2019
Subject(s):
Child of Impaired Parents
Community Health Centers
Community Health Services
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Adolescent
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Child
Community Mental Health Services
Drug Overdose -- prevention & control
Humans
United States